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EXECUTIVE SUMMARY 
 
Abstract: The purpose of this study was to evaluate if patients who took Angiotensin Converting 
Enzyme (ACE) inhibitors the morning of surgery for Posterior Lumbar Interbody Fusion (PLIF) 
required more treatment for intraoperative hypotension.                                                                                                                               
Introduction: PLIF is a surgical procedure used to correct spinal disorders that include 
compression, instability, pathological lesions, deformities, and pain. PLIF is completed utilizing 
the prone position for optimal access to the lumbar spine. Complications associated with prone 
position have included Post-Operative Vision Loss (POVL), compression of abdominal vessels, 
and head and neck venous compression resulting in neurologic injury. Currently, there are no set 
recommendations on ACE Inhibitor continuation before surgery, unlike those on a beta 
antagonist. There is a lack of research on the effect of the continuation of ACE inhibitors on 
intraoperative hypotension and vasopressor administration.                                                                                                      
Methodology: This study used a retrospective, case-control study design. A chart review was 
conducted from January 1, 2007, through January 1, 2017 on patients undergoing PLIF. A total of 
200 patients were included in this study sepearted into two groups, those who held their ACE 
inhibitors and those who continued their ACE inhibitors. Patient information collected included: 
amount of phenylephrine received, amount of ephedrine received, lowest systolic blood pressure, 
and lowest diastolic blood pressure. The age and BMI was compared using t-tests and chi-square 
tests for gender and ASA physical status. A total of two linear regressions were completed to 
examine the lowest systolic blood pressure, lowest diastolic blood pressure, total phenylephrine 
dose, and total ephedrine dose.                                                                                                  
Results: The mean age of the total study sample was 57.25 ± (12.57). There were 47.5% male 
patients and 52.5% female patients. The mean BMI was 31.01± (6.71). The ASA physical status 
ranged from 2 to 4 with 27% ASA 2, 69% ASA 3, and 4% ASA 4. There was no statistically 
significant difference found in age, gender, BMI, or ASA physical status between groups. The 
mean systolic blood pressure was 84.38 ± (7.45), mean diastolic blood pressure was 44.61 ± 
(7.38), mean ephedrine doses were 4.72 ± (4.10), and mean phenylephrine doses were 3.57 ± 
(4.40). Data did not support a statistically significant difference in lowest systolic blood pressure, 
lowest diastolic blood pressure, total phenylephrine dose, or total ephedrine dose between groups.                                                                                                                  
Discussion: This study did not find an association between patients taking ACE inhibitors and 
increased requirements of vasopressors, lower systolic blood pressure, or lower diastolic blood 
pressure. The results of this current study are inconsistent with existing literature and could be 
explained by the retrospective nature of the study, small sample size, and only one hospital 
network used for patients. There were several limitations identified and discussed in this study.                                                  
Conclusion: In this study, the use of ACE inhibitors the morning of surgery was not associated 
with more doses of vasopressor medications, lower systolic blood pressure, or lower diastolic 
blood pressure in patients undergoing PLIF.                                    
Implications/Recommendations: This study provided clinical relevance to anesthesia 
practitioners, researchers, and physicians about the use of ACE inhibitors for patients undergoing 
PLIF. Knowledge of ACE inhibitors and their effects help anesthesia providers customize the 
anesthetic to optimize patient safety. 
Key Words: ACE inhibitors, hypotension, posterior lumbar interbody fusion, vasopressors 
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INTRODUCTION 
Background and Significance  
Posterior Lumbar Interbody Fusion (PLIF) is a surgical procedure used to correct 
spinal disorders that include compression, instability, pathological lesions, deformities, 
and pain (Takahashi et al, 2016). PLIF is completed utilizing the prone position for 
optimal access to the lumbar spine. Complications associated with prone position have 
included Post-Operative Vision Loss (POVL), compression of abdominal vessels, and 
head and neck venous compression resulting in neurologic injury (Pierce & Kendrick, 
2010). 
Prone positioning and prolonged procedures pose significant challenges for 
anesthesia providers to maintain hemodynamic stability and to avoid the resulting 
decreased venous return from compressed abdominal vessels which reduces cardiac 
output (Nagelhout & Plaus, 2014). POVL has often been reported in prone spine surgery, 
and risk factors contributing to vision loss have included hypotension, massive infusions 
of intravenous fluids, lengthy procedures, and anemia (Pierce & Kendrick, 2010). 
Nagelhout and Plaus (2014) described the importance of proper positioning during prone 
spine surgery to prevent eye injuries and prevent abdominal compression. Rapid 
intervention and assessment must be paramount if sudden hypotension occurs and all 
members of the surgery team should be informed to efficiently institute appropriate 
treatment and prevent life-changing complications (Nagelhout & Plaus, 2014).   
     The Renin-Angiotensin-Aldosterone System (RASS) provides an integral role in the 
regulation of fluid balance and autonomic nervous system blood pressure control (Chopra, 
Baby, & Jacob, 2011). Hemodynamic control of blood pressure is controlled by three 
regulatory systems during anesthesia, the Sympathetic Nervous System, renin-
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angiotensin system, and vasopressin (Schulte, Ziefler, Philippi-Hohne, Kaczmarczyk, & 
Boemke, 2011). Inhibition of the RASS system causes a reduction in fluid volume and 
decreased blood pressure by preventing the conversion of angiotensin I to angiotensin II 
which decreases peripheral vascular resistance, reduces aldosterone, norepinephrine, and 
plasma antidiuretic hormone (Ma, Kam, Yan, & Lam, 2010). ACE inhibitors block 
angiotensin II, a potent vasoconstrictor, which has shown to be highly useful in the 
treatment of hypertension and congestive heart failure (Helal & Lane, 2014). Drugs in the 
ACE inhibitor family include captopril, enalapril, lisinopril, ramipril, quinapril, and 
fosinopril (Pilote. Abrahamowicz, Eisenberg, Humphries, Behlouli, & Tu, 2008). 
RASS antagonists, including ACE inhibitors and their continuation have been linked 
to intraoperative hypotensive episodes during anesthesia. Studies have found growing 
evidence that continuing RASS antagonists could be related to adverse outcomes, such as 
renal failure and death, and temporary withdrawal could attenuate intraoperative 
hypotension and hypovolemia (Auron, Harte, Kumar, & Michota, 2010). Hypotension 
has been associated with renal failure and as the severity of hypotension increases the risk 
for renal injury increases (Lehman, Saeed, Moody, & Mark, 2010).  
Perioperative continuation of ACE inhibitors has been linked to refractory 
intraoperative hypotension, and varying degrees of hypotension can occur depending on 
the variables of the surgical procedure (Thoma, 2013). Renal excreted ACE inhibitors 
have a half-life elimination of 10 hours, and this can explain why withdrawing 8 to 24 
hours could significantly reduce intraoperative hypotension (Thoma, 2013).  
There are a growing number of studies reporting that patients are at increased risk for 
intraoperative hypotension when patients have been treated with ACE inhibitors 
 3 
compared to those who were not (Auron et al., 2010). Current research has shown that 
continuation of ACE inhibitors has been linked to intraoperative hypotension and 
withholding these drugs could reduce the likelihood (Smith & Jackson, 2010). Treatment 
of hypotension during anesthesia is achieved with Intravenous (IV) fluid bolus and 
administration of vasoactive medications, such as phenylephrine and ephedrine Lonjaret, 
Lairez, Minville, & Geeraerts, 2014). Chronic ACE inhibitor therapy leads to blunting of 
the RASS system resulting in vasoplegic syndrome causing low systemic vascular 
resistance and high cardiac output (Hedman, Mann, Spulecki, & Castner, 2016). 
Vasoplegia leads to poor organ perfusion due to lack of Systemic Vascular Resistance 
(SVR) and is minimally responsive to agents that increase SVR (Hosseinian, Weiner, 
Levin, & Fischer, 2016). 
Literature Review  
     Due to the lack of research regarding ACE inhibitors in non-cardiac surgery and the 
retrospective nature of this study, both non-cardiac and cardiac studies were analyzed. 
Also, research has been limited to procedures performed in the prone position and ACE 
inhibitors; therefore, other positions were included. There have been few studies 
involving ACE inhibitors without the addition of Angiotensin Receptor Blockers (ARB), 
so they were also included in this review. Some research studies have argued that it is 
advantageous to stop ACE inhibitors before surgery, while others have supported their 
continuation. This review described several studies that have argued the continuation or 
withdraw of ACE inhibitor therapy. 
     A retrospective study performed by Trentman et al. (2011) reviewed 384 patients 
undergoing shoulder surgery in the beach chair position containing two groups: those 
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taking at least one antihypertensive medication and those not taking antihypertensive 
drugs, including 199 and 185 patients, respectively. The antihypertensive group presented 
more episodes of hypotension, 62% in those taking antihypertensive medications versus 
44% who did not receive antihypertensive therapy with a mean episode per case of 1.7 to 
1.2, respectively. Those who took antihypertensive medications received more 
vasopressor administrations, 75%, versus those who did not take antihypertensive therapy, 
54%, with a mean value of 3.0 to 2.1, respectively. The timing of ACE inhibitors and 
angiotensin receptor antagonist administration did not affect intraoperative hypotension. 
     Roshanov et al. (2017) conducted an international prospective cohort study on 14, 687 
patients of whom 4,802 were receiving ACE inhibitors or angiotensin II receptor blockers 
before non-cardiac surgery. The authors reported that patients who withheld their ACE 
inhibitors or angiotensin II receptor blockers in the 24 hours before surgery were less 
likely to experience death, stroke, myocardial injury (adjusted relative risk 0.82; 95% CI, 
0.70 to 0.96; P = 0.01), or intraoperative hypotension (adjusted relative risk, 0.80; 
95% CI, 0.72 to 0.93; P < 0.001).  
     Comfere et al. (2005) performed a retrospective study of 267 hypertensive patients 
undergoing elective non-cardiac surgery under general anesthesia who took ACE 
inhibitors or angiotensin receptor antagonist. In the preoperative screening period, 
patients were asked to continue or hold their ACE inhibitors or angiotensin receptor 
antagonist up to 24 hours and the number of hours from the last dose was recorded. 
Results of the study showed that withdrawing ACE inhibitors or angiotensin receptor 
antagonist at minimum 10 hours before anesthesia reduced immediate post-induction 
hypotension, and medications which were taken closer to surgery, less than 10 hours, 
 5 
were more likely to incur hypotension.  
     Rajgopal, Rajan, Sapru, and Paul (2014) conducted a randomized prospective double-
blinded study to determine the effect of preoperative discontinuation of ACE inhibitors or 
angiotensin II receptor antagonists on intraoperative blood pressure after induction of 
anesthesia from 2008 to 2012. A total of 60 patients were included in the study and 
randomized into two groups, 30 patients that took ACE inhibitors or angiotensin II 
receptor antagonists and 30 patients who stopped therapy the day before surgery. The 
results showed that intraoperative hemodynamics could be more safely managed when 
ACE inhibitors or angiotensin II receptor antagonists were held on the day of surgery. 
The authors found a significant reduction in systolic blood pressure with a mean 
difference 37.67 versus 3.47, diastolic blood pressure with a mean difference 3.47 versus 
1.93, and mean arterial pressure with a mean difference 24.82 versus 0.13 in the group 
that continued their ACE inhibitor or angiotensin II receptor antagonist (p<0.01, p<0.05, 
p<0.01 respectively).  
     Schulte et al. (2011) examined the effects of long-term treatment with ACE inhibitors 
and hemodynamic regulation during Total Intravenous Anesthesia (TIVA) in a 
prospective study. The study included 36 patients undergoing TIVA for minor surgery 
with 17 patients that continued ACE inhibitors and 19 patients as controls. The 
researchers showed that long-term ACE inhibitor therapy did not exaggerate hypotension 
as long as patients’ were well hydrated and vasopressors were promptly applied. There 
was no difference in the amount of fluids or vasopressors used between each group 
(p<0.05).  
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     A retrospective cohort study containing 1,358 adult patients who underwent cardiac 
surgery was conducted by Arora et al. (2008) to assess the long-term use of ACE 
inhibitors/ARB and the association of Acute Kidney Injury (AKI) after cardiac surgery. 
Intraoperative and postoperative dependent variables associated with AKI were 
hypotension during surgery or postoperative hypotension and the use of vasopressors. It 
was reported that preoperative use of ACE inhibitors/ARB was associated with a 27.6 % 
higher risk of postoperative AKI. The ACE inhibitor/ARB group experienced greater 
intraoperative hypotension than the non- ACE inhibitor/ARB group 47.67% versus 
41.41%, respectively (p=0.025). 
     Vijay, Grover, Coulson, and Myles (2016) performed a prospective observational 
study of 323 patients with 83 patients stopping ACE inhibitor/ARB therapy and 240 
continuing their treatment. It was shown no significant difference in intraoperative 
vasopressor use, fluid intake, or lowest systolic blood pressure. Despite findings, the 
researchers recommended withholding ACE inhibitors/ARB before major surgery where 
large fluid shifts or hypotension could occur, although extra caution should be given to 
those with heart failure and the risks of exacerbation when ACE inhibitors/ARB were 
withheld.  
     A randomized prospective, single-blind study was conducted by Twersky, Goel, 
Narayan, and Weedon (2014) to observe the effects of ACE inhibitors and ARB on 
arterial blood pressure recordings during same day ambulatory surgery. The study 
contained 640 patients randomly assigned to two groups: those who continued and those 
who discontinued ACE inhibitor/ARB therapy. The researchers assessed the primary 
outcomes of the presence of Hypertension (HTN) before surgery, cancellations due to 
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HTN, prolongation and adverse effects, and HTN in the postoperative period. The results 
of the study showed that discontinuation of ACE inhibitor/ARB therapy did not result in 
an increased preoperative or postoperative HTN providing evidence for the safety of 
discontinuation of ACE inhibitors/ARB on the day of surgery. 
Statement of the Problem and Research Purpose  
     The objectives of this study were to evaluate if patients who took ACE inhibitors the 
morning of surgery versus those who withheld them required more doses of vasopressors, 
had lower systolic blood pressures, and lower diastolic blood pressures.  
Hypotension after the induction of anesthesia is common due to the subsequent 
reduction in vascular tone and cardiac depression. Hypotension can be further 
exaggerated when induction of anesthesia is compounded with the use of 
antihypertensive medications. Prolonged hypotension can cause deleterious outcomes 
when refractory to traditional treatment measures causing failure to perfuse vital systemic 
capillary networks (Trotter, 2012). Patients who take ACE inhibitors in the perioperative 
period could be faced with refractory hypotension producing previously mentioned 
adverse outcomes.   
Currently, there are clear guidelines on continuation for some antihypertensive 
medications preoperatively for non-cardiac surgery, but clear recommendations are still 
lacking for ACE inhibitors (Fleisher & Fleishmann, 2014). According to the 2014 
American College of Cardiology/American Heart Association Task Force on Practice 
Guidelines on perioperative cardiovascular evaluation and management of patients 
undergoing non-cardiac surgery, the summary found ACE inhibitor continuation to be 
reasonable during the perioperative period (Fleisher & Fleishmann, 2014). Vijay et al. 
(2016) found that patients experienced no adverse effects by withholding ACE inhibitor 
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or angiotensin II receptor blockers and recommending withholding therapy during 
surgeries that involve significant fluid shifts, hypotension, or large IV fluid requirements.   
Further research in the perioperative use of ACE inhibitors could improve clinical 
outcomes of patients and clinical practice at CAMC and other hospitals performing PLIF. 
The goal of this research was to determine if patients who took their ACE inhibitors the 
morning of surgery presented lower systolic blood pressures, lower diastolic blood 
pressure, and required more doses of vasopressors than those who did not take their ACE 
inhibitor the morning of surgery.  
METHODOLOGY 
Research Hypothesis  
     The first hypothesis for this study was patients who took ACE inhibitors the morning 
of surgery required more doses of vasopressor medications to treat hypotension versus 
those who did not take ACE inhibitors the morning before surgery. The second 
hypothesis was patients who took ACE inhibitors the morning of surgery presented lower 
systolic blood pressures versus those who did not receive ACE inhibitors the morning of 
surgery. Lastly, the third hypothesis for this study was patients who took ACE inhibitors 
the morning of surgery had lower diastolic blood pressures versus those who did not 
receive ACE inhibitors the morning of surgery. 
Research Design and Setting 
     A review of electronic medical records at CAMC was conducted using patients who 
took ACE inhibitors at home who required PLIF under general from January 1, 2007, 
through January 1, 2017 (McKesson Corporation, 2017). This study evaluated if patients 
who received ACE inhibitors the morning of surgery for PLIF required more doses of 
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vasopressor medications for hypotension treatment, had lower systolic blood pressures, 
and lower diastolic blood pressures than those who did not take ACE inhibitors for the 
same procedure. 
     The study design was a retrospective, case-control study design. A retrospective 
design was chosen because data can be collected at CAMC where patient records can be 
easily accessed. The case-control design allowed for the identification of hypotension and 
ACE inhibitor therapy during PLIF. A retrospective, case-controlled study design was 
employed to analyze the data to gain substantial research findings while adhering to 
limited financial and time constraints when compared with alternative study designs 
(Schulz & Grimes, 2002). 
Sample Population and Description of Sample 
     The sample population for this study included patients with home medications in the 
ACE inhibitor family who underwent PLIF at CAMC. Two hundred patients who met the 
inclusion criteria were included in this study. This sample included 100 patients who took 
their ACE inhibitor the morning of surgery and 100 patients who did not receive an ACE 
inhibitor the morning of surgery. The patients in the sample were identified using the 
International Classification of Diseases 9th revision (ICD-9) and International 
Classification of diseases 10th revision (ICD-10) codes. Due to the recent nationwide 
change from ICD-9 to ICD-10 in 2015, both codes were included to fulfill all inclusion 
and exclusion criteria. ICD- 9 codes 81.08 (Lumbar and lumbosacral fusion of the 
anterior column, posterior technique) and ICD-10 code OSG10AJ (fusion of two or more 
lumbar vertebral joints with interbody fusion device, posterior).   
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Inclusion Criteria: 
1. Patient Age 18-80 years old  
2. Patient ASA physical status classification I-IV 
3. Home medication in the ACE inhibitor family 
4. Patients undergoing PLIF  
Exclusion Criteria: 
1. Patients less than 18 years of age or greater than 80 years of age 
2. Patients ASA classification greater IV  
Procedure/Protocol  
     A chart review was conducted from electronic medical records at CAMC on patients 
who had PLIF with concurrent ACE inhibitor therapy from January 1, 2007, to January 1, 
2017. CAMC is a non-profit, 956-bed regional referral and academic medical center 
(CAMC, 2017a). There are three hospitals located in Charleston, West Virginia: General, 
Memorial, and Women & Children’s. The fourth hospital, Teays Valley Hospital, is 
located in Teays Valley, West Virginia (CAMC, 2017a). Preoperative assessments and 
intraoperative data were collected from the patients’ anesthesia record. Preoperative 
collection data included control variables: age, ASA physical status, home medication list, 
gender, and Body Mass Index (BMI). BMI was calculated by using the height and weight 
obtained from the anesthesia record. BMI is an indicator for amount of body fat and uses 
the following formula: Weight (kilograms)/ Height (meters) squared (Centers for Disease 
Control and Prevention, 2015). Gender was classified as male or female. Intraoperative 
data included total number of ephedrine doses received, number of phenylephrine doses 
received, lowest systolic blood pressures recorded in millimeter of mercury (mmHg), and 
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lowest diastolic blood pressures recorded in millimeter of mercury (mmHg). 
Phenylephrine and ephedrine provided two different mechanisms of action to achieve 
their vaso-constrictive properties; therefore, there was no formula to convert dose 
equivalents between the two drugs. Doses of Ephedrine were quantified as 5 milligrams, 
and doses of Phenylephrine were quantified as 100 micrograms. The ASA classification 
is a numeric scale developed by the American Society of Anesthesiologists to determine 
the general health of the patient (American Society of Anesthesiologists, 2014). The 
classifications were:  
ASA 1. A normal patient who is healthy. 
ASA 2. A patient with mild systemic disease. 
ASA 3. A patient with severe systemic disease. 
ASA 4. A patient with a severe systemic disease that is a constant threat to life. 
ASA 5. A moribund patient who is not expected to survive without the operation.  
ASA 6. A brain-dead patient whose organs are being removed for donor purposes. 
Data Collection and Instruments 
     Microsoft Excel was used to organize collected data in a systematic manner. Patients 
were individually numbered in the order the data was received. The number did not, in 
any way, link the data to the patient it corresponded with. The patients were randomly 
assigned by to one of two groups: 1) Received ACE inhibitor the morning of surgery, 2) 
Did not receive ACE inhibitor the morning of surgery.  
Statistical Design and Analysis  
     The purpose of this research was to evaluate if perioperative ACE inhibitor therapy 
was associated with increased use of vasopressors during posterior lumbar interbody 
fusion. First, a T-test was performed to determine if the ACE inhibitor group and the non-
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ACE inhibitor group shared similarities in age and BMI. Chi-squared test was used to 
compare the group’s gender and ASA physical status to determine if the groups were 
similar in these aspects. Two linear regressions were used to determine if there was 
relationship between ACE inhibitor therapy and a number of doses of the vasopressors 
phenylephrine and ephedrine received, lowest systolic blood pressure, and lowest 
diastolic blood pressures. A p-value <0.5 was considered statistically significant. SPSS 
software version 22 was utilized to determine statistical relevance between collected data 
(SPSS IBM Company, 2017). 
Ethical Considerations 
     This study was approved by the CAMC and West Virginia University-Charleston 
Division Institutional Review Board on August 4, 2014 (Appendix C). 
RESULTS 
Presentation, Analysis, and Interpretation of the Data 
     The total study sample consisted of 200 patients ages 18-80 years old presenting to 
CAMC Hospitals for PLIF surgery. The mean age of the total study sample was 57.25 ± 
(12.57), 47.5% male and 52.5% female, mean BMI 31.01± (6.71), and ASA 2 was 27%, 
ASA 3 was 69%, ASA 4 was 4% (Table 1).  
     The study sample of 200 patients was then divided into equal groups containing 100 
patients by those who took an ACE inhibitor and those who did not take an ACE inhibitor. 
The mean age in the received ACE inhibitor group (group A) was 58.77 ± (12.74), and 
the did not receive ACE inhibitor group (group B) 55.74 ± (12.27) with no statistically 
significant mean difference between groups, (p > .05) (Table 1). Group A consisted of 
47% male and 53% female with a mean BMI 30.37 ± (6.447) and group B consisted of 
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48% male and 52% female with a mean BMI 31.64 ± (6.930) and no statistically 
significant mean difference in either category, (p> .05) (Table 1). ASA physical status in 
group A contained 24% ASA 2, 73% ASA 3, and 3% ASA 4; Group B contained 30% 
ASA 2, 65% ASA 3, and 5% ASA 4 with no statistically significant mean difference 
between groups (p> .05) (Table 1).  
Table 1: Demographic and Clinical Characteristics of Patients Who Underwent Posterior 
Lumbar Interbody Fusion Surgery and comparison of age, gender, BMI, and ASA 
between groups 
Variable  Total Sample Study Groups Statistical Value 
Total 
N=200 
Mean (SD) 
Received ACE 
inhibitor  
N-100 (50%) 
Mean (SD)  
Did Not receive 
ACE inhibitor  
N-100 (50%)  
Mean (SD) 
 
p-Value 
Age (years) 
N=200 
 
57.25 (12.567) 
 
58.77 (12.739) 
 
55.74 (12.269) 
 
NS 
Gender N (%) 
Male 
Female 
N=200 
 
47.5% 
52.5% 
 
47% 
53% 
 
48% 
52% 
 
NS 
NS 
 
BMI (kg/m2) 
 
 
31.01 (6.707) 
 
30.37 (6.447) 
 
31.64 (6.930) 
 
NS 
ASA N (%) 
2 
3 
4 
 
54 (27%) 
138 (69%) 
8 (4%) 
 
24 (24%) 
73 (73%) 
3 (3%) 
 
30 (30%) 
65 (65%) 
5 (5%) 
 
NS 
NS 
NS 
NS= Not significant (p> 0.05), SD= Standard Deviation, BMI=Body Mass Index, ASA= American Society 
of Anesthesiologist physical status classification 
     The total sample presented a mean systolic blood pressure of 84.38 ± (7.45), a mean 
diastolic blood pressure of 44.61 ± (7.38), mean ephedrine doses 4.72 ± (4.10), and a 
mean phenylephrine doses of 3.57 ± (4.40) (Table 2). A t-test was preformed to 
determine the mean difference between group A and group B, and there was no 
statistically significant difference found between lowest systolic blood pressure, lowest 
diastolic blood pressure, total ephedrine doses, and total phenylephrine doses (p > .05). 
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Group A presented a mean lowest systolic blood pressure of 83.38 ± (6.80), and group B 
presented a mean lowest systolic blood pressure of 85.37 ± (7.96) which was not 
statistically significant (p> .05). The mean lowest diastolic blood pressure in group A was 
42.14 ± (6.80), and the group B mean lowest diastolic blood pressure was 47.07 ± (7.158) 
(p> .05). Group A received a mean 5.10 ± (4.08) ephedrine doses, and group B received a 
mean 4.34 ± (4.12) ephedrine doses (p> .05). Group A received a mean 3.60 ± (4.90) 
phenylephrine doses, and group B received a mean 3.54 ± (3.88) phenylephrine (p> .05) 
(Table 2).  
Table 2: Comparison of Preoperative ACE Inhibitor Administration on Lowest Systolic 
Blood Pressure, Lowest Diastolic Blood Pressure, Total Ephedrine Doses, and Total 
Phenylephrine Doses in Those Who Underwent Posterior Lumbar Interbody Fusion 
Variable  Total Sample Study Groups Statistical Value  
Total 
N=200 
Mean (SD) 
Received ACE 
inhibitor  
N=100  
Mean (SD) 
Did Not receive ACE 
inhibitor  
N=100  
Mean (SD) 
p-Value 
Lowest Systolic 
Blood Pressure  
84.38 (7.452) 83.38 (6.795) 85.37 (7.965) NS 
Lowest Diastolic 
Blood Pressure 
44.61 (7.378) 42.14 (6.797) 47.07 (7.157) NS 
Ephedrine Doses 4.723 (4.105) 5.100 (4.0788) 4.345 (4.1186) NS 
Phenylephrine 
Doses 
3.570 (4.404) 3.600 (4.8933) 3.540 (3.8780) NS 
NS= Not significant  (p> 0.05), SD= Standard Deviation 
     A linear regression was conducted between lowest systolic blood pressure and age, 
gender, BMI, ASA physical status, and ACE inhibitor consumption. Age and gender 
were associated with lowest systolic blood pressure which was statistically significant, 
(p= .001) and (p= .036), respectively. BMI, ASA physical status, and ACE inhibitor 
consumption did not show a statistically significant association (p> .05), (Table 3).  
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Table 3: Linear Regression Analysis between Age, Gender, BMI, and ASA Physical 
Status and Lowest Systolic Blood Pressure in Patients Who Underwent Posterior Lumbar 
Interbody Fusion.   
Variable: Age, Gender, BMI, and ASA. * Indicates Statistical Significance at (p<. .05), BMI= Body Mass 
Index, ASA= American Society of Anesthesiologist physical status classification, NS= Not Statistically 
Significant (p> .05) 
    A second linear regression was performed between the lowest diastolic blood pressure 
and age, gender, BMI, and ASA physical status. It was found to show a statistically 
significant association between lowest diastolic blood pressure and age, gender, and ACE 
inhibitor consumption (p < .05). BMI and ASA showed no statistically significant 
difference (p> .05), (Table 4). 
Table 4: Linear Regression Analysis between Age, Gender, BMI, and ASA Physical 
Status and Lowest Diastolic Blood Pressure in Patients Who Underwent Posterior 
Lumbar Interbody Fusion.   
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 
B Std. Error, Beta 
1 (Constant) 54.803 4.150  13.204 .001 
Age -.096 .041 -.163 -2.317 *.022 
Gender  (Male=1 Female =0) 2.570 .961 .174 2.673 *.008 
BMI -.020 .076 -.018 -.266 NS 
ASA (I-IV) -1.092 .981 -.075 -1.114 NS 
Ace Inhibitor (1=took  
0=did not take) -4.597 .967 -.312 -4.756 *.001 
Variable: Age, Gender, BMI, and ASA. * Indicates Statistical Significance at (p<. .05), BMI= Body Mass 
Index, ASA= American Society of Anesthesiologist physical status classification, NS= Not Statistically 
Significant (p> .05) 
 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 
B Std. Error Beta 
1 (Constant) 90.303 4.351  20.757 .001 
Age -.160 .043 -.270 -3.708 *.001 
Gender  (Male=1  
Female =0) 2.125 1.008 .143 2.109 *.036 
BMI .036 .080 .032 .449 NS 
ASA (I-IV) .673 1.028 .046 .654 NS 
Ace Inhibitor (1=took 
0=did not take) -1.465 1.013 -.099 -1.446 NS 
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DISCUSSION 
Discussion of Study Results  
     The purpose of this study was to determine if there was an association between taking 
ACE inhibitors the morning before surgery and increased total doses of vasopressor 
medications, lower systolic blood pressures, or lower diastolic blood pressures during 
surgery for PLIF. The hypotheses predicted that those who took ACE inhibitors would 
require more doses of vasopressor medications, ephedrine or phenylephrine, have lower 
systolic blood pressures, and have lower diastolic blood pressures. Phenylephrine and 
ephedrine have two different mechanisms of action, so linear regressions were performed 
to compare total phenylephrine and ephedrine doses to demographic factors age, gender, 
BMI, and ASA physical status. The researcher wanted to have equal groups of those who 
took ACE inhibitors before surgery for PLIF and those who did not, therefore, 100 
patients from each group were chosen. 
     The results of Chi-square and Independent t-tests showed there were not statistically 
significant mean difference in age, BMI, gender, or ASA physical status between the two 
groups (Table 1). T-tests demonstrated no statistically significant mean difference in total 
ephedrine doses, total phenylephrine doses, lowest systolic blood pressure, or lowest 
diastolic blood pressure (Table 2). These findings do not support the hypotheses. 
     The results did not show an association between ACE inhibitor consumption before 
surgery and increased total vasopressors doses, lowest systolic blood pressures, or lowest 
diastolic blood pressures. These findings are inconsistent with the conclusions of a study 
done by Comfere et al. (2005). These scholars found during the first 30 minutes after 
anesthetic induction that 60% of those who continued ACE inhibitors (<10 hours) 
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compared to 46% who stopped ACE inhibitors experienced hypotension more frequently 
(p=0.02). The authors found that there was no significant difference (p<0.05) in 
vasopressor administration between groups, which was consistent with the results of this 
study.  
     A retrospective study conducted by Trentman et al. (2011) found that patients taking 
antihypertensive medications, including ACE inhibitors, had more intraoperative 
hypotensive episodes and vasopressor administrations (p=0.01). The researchers 
concluded that preoperative use (<10 hours) of antihypertensive medications was 
associated with an increased incidence of intraoperative hypotension and require more 
vasopressor medications to maintain normal blood pressure. These results were 
inconsistent with the present study. An international prospective cohort study by 
Roshanov et al. (2017) also found that patients who withheld ACE inhibitors/ARB’s 24 
hours before surgery were less likely to suffer from intraoperative hypotension. The 
results of the present study could be explained by the study’s relatively small sample size, 
presence of only one hospital system, and the retrospective design.  
Study Limitations 
     There were many limitations identified in this study. The retrospective, case-control 
design limits findings to only associations and could result in inaccurate documentation 
or researcher bias (Schulz & Grimes, 2002). Blood pressure was only documented every 
5 minutes on the anesthesia record so that the recorded blood pressures may not have 
been the lowest blood pressure during the procedure. All patients involved in this study 
were within the CAMC network and may not represent the overall population. 
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     The retrospective design of this study allowed for the use of various anesthetic 
techniques that had different impacts on blood pressure. The study did not account for 
any medications that could negatively impact blood pressure, such as opioid infusions, 
diuretics, angiotensin II receptor blockers, beta-receptor antagonists, or calcium channel 
antagonists. Multiple patients were treated for hypotension after receiving sufenta 
continuous IV drips. The study was limited to patients who only received phenylephrine 
or ephedrine for hypotensive treatment and did not account for those who received 
crystalloid fluid bolus or vasopressin administration. The use of crystalloid's and/or 
vasopressin could decrease the amount of phenylephrine and ephedrine used to treat 
hypotension. Several patients also received phenylephrine IV continuous infusions for 
hypotension and total micrograms were not recorded, so those cases could not be 
converted into 100 microgram doses. 
CONCLUSION 
     In this study, the use of ACE inhibitors the morning of surgery was not associated 
with more doses of vasopressor medications, lower systolic blood pressure, or lower 
diastolic blood pressure in patients undergoing PLIF.  
IMPLICATIONS AND RECOMMENDATIONS 
      This study provided clinical relevance to anesthesia practitioners, researchers, and 
physicians about the use of ACE inhibitors for patients undergoing PLIF. Knowledge of 
ACE inhibitors and their effects help the anesthesia provider customize the anesthetic to 
optimize patient safety. This research did not support the association that patients who 
took ACE inhibitors the morning of surgery for PLIF would require more doses of 
vasopressor medications, have lower systolic blood pressure, or lower diastolic blood 
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pressures. Studies have proven an association between preoperative ACE inhibitor use 
and lower intraoperative blood pressure, greater vasopressor administration, and those 
who withheld ACE inhibitors were less likely to suffer death, stroke, or myocardial 
infarction. For this reason, anesthesia providers should consider these findings before 
continuing an anesthetic for patients undergoing PLIF. Due to the limited studies on 
preoperative use of ACE inhibitor and PLIF further research should be done to confirm 
these results and provide clear recommendations on ACE inhibitors and PLIF. New 
research should be continued on preoperative ACE inhibitor use and perioperative blood 
pressure for PLIF and other related procedures. Additionally, research using a 
randomized, prospective study should be implemented that could control factors such as 
anesthetic technique, other vasopressor medications, timing of ACE inhibitor 
consumption, and continuous IV vasopressors.  
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APPENDIX A: DATA COLLECTION TOOL 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient Study Number Patient Identification Number 
1  
2  
3  
4  
…  
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APPENDIX B: DATA COLLECTION TOOL 
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number 
Age 
(yrs) 
Gender 
Male= 1 
Female= 
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ASA 
Physical 
Status 
(I-IV) 
Weight 
(KG) 
BMI 
Kg/m2 
Lowest 
systolic 
BP 
(mmHg) 
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diastolic 
BP 
(mmHg) 
Vasopressor 
administration 
(mg) 
1         
2         
3         
4         
…         
200         
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